| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $8.5M | — | +41.1% |
| SG&A Expense | $6.9M | — | +400.9% |
| Operating Income | -$15.4M | — | -107.6% |
| Pre-tax Income | -$13.8M | — | -56.6% |
| Income Tax | $0 | — | — |
| Net Income | -$13.8M | — | -56.6% |
| EPS (Basic) | -$0.69 | — | +82.6% |
| EPS (Diluted) | -$0.69 | — | +82.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $238.9M | +147.9% | — |
| Current Assets | $253.4M | +132.9% | — |
| Total Assets | $258.4M | +123.0% | — |
| Current Liabilities | $6.7M | -22.3% | — |
| Total Liabilities | $8.3M | -18.6% | — |
| Stockholders' Equity | $250.1M | +353.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.5M | — | -65.2% |
| Capital Expenditures | $676K | — | +312.2% |
| Investing Cash Flow | -$1.7M | — | -916.5% |
| Financing Cash Flow | $157.8M | — | +214.9% |
| Free Cash Flow | -$14.2M | — | -70.0% |
| +463.3% |